Preliminary Efficacy of the NVX-CoV2373 Covid-19 Vaccine Against the B.1.351 Variant
Vivek Shinde, Sutika Bhikha, Zaheer Hoosain, Moherndran Archary, Qasim Bhorat, Lee Fairlie, Umesh Lalloo, Mduduzi S. L. Masilela, Dhayendre Moodley, Sherika Hanley, Leon Fouche, Cheryl Louw, Michele Tameris, Nishanta Singh, Ameena Goga, Keertan Dheda, Coert Grobbelaar, Gertruida Kruger, Nazira Carrim-Ganey, Vicky Baillie, View ORCID ProfileTulio de Oliveira, Anthonet Lombard Koen, Johan J. Lombaard, Rosie Mngqibisa, As’ad Ebrahim Bhorat, Gabriella Benadé, Natasha Lalloo, Annah Pitsi, Pieter-Louis Vollgraaff, Angelique Luabeya, Aliasgar Esmail, Friedrich G. Petrick, Aylin Oommen Jose, Sharne Foulkes, Khatija Ahmed, Asha Thombrayil, Lou Fries, Shane Cloney-Clark, Mingzhu Zhu, Chijioke Bennett, Gary Albert, Emmanuel Faust, Joyce S. Plested, Andreana Robertson, Susan Neal, Iksung Cho, Greg M. Glenn, Filip Dubovsky, Shabir A. Madhi, for the 2019nCoV-501 Study Group
doi: https://doi.org/10.1101/2021.02.25.21252477
Vivek Shinde
1Novavax, Inc., 20 Firstfield Road, Gaithersburg, MD, USA
MD, MPHSutika Bhikha
2South African Medical Research Council, Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
MBBSZaheer Hoosain
3Josha Research Centre, Bloemfontein, Free State, South Africa
MBChBMoherndran Archary
4Paediatric Infectious Diseases Unit, University of KwaZulu-Natal, Durban, South Africa
PhDQasim Bhorat
5Soweto Clinical Trials Centre, Johannesburg, South Africa
MBBCh, MScLee Fairlie
6Wits Reproductive Health and HIV Institute, University of the Witwatersrand, Johannesburg, South Africa
MBChBUmesh Lalloo
7Respiratory and Critical Care Unit, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa
MBChBMduduzi S. L. Masilela
8Setshaba Research Centre, Tshwane, South Africa
MBChBDhayendre Moodley
9Department of Obstetrics and Gynaecology, University of KwaZulu-Natal, Durban, South Africa
PhDSherika Hanley
10Centre Aids Prevention Research South Africa (CAPRISA), University of KwaZulu-Natal, Durban, South Africa
MBBSLeon Fouche
11Limpopo Clinical Research Initiative, Rustenburg, North-West, South Africa
MBChBCheryl Louw
12Madibeng Centre for Research, Department of Family Medicine, School of Health, University of Pretoria, Pretoria, South Africa
MBChBMichele Tameris
13South African TB Vaccine Initiative, University of Cape Town, Cape Town, South Africa
MBChBNishanta Singh
13South African TB Vaccine Initiative, University of Cape Town, Cape Town, South Africa
MBChBAmeena Goga
14Health Systems Research Unit and HIV Prevention Research Unit, South African Medical Research Council, Cape Town, South Africa
MBChBKeertan Dheda
15Centre for Lung Infection and Immunity, Division of Pulmonology, Department of Medicine and UCT Lung Institute, University of Cape Town, Cape Town, South Africa
MBBChCoert Grobbelaar
16Aurum Institute, University of Pretoria, Pretoria, South Africa
MBChBGertruida Kruger
17MERC Research, Middelburg, South Africa
MBChBNazira Carrim-Ganey
18PEERMED Clinical Trial Centre, Kempton Park, South Africa
MBBChVicky Baillie
2South African Medical Research Council, Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
PhDTulio de Oliveira
19Kwazulu-Natal Research Innovation and Sequencing Platform (KRISP), University of KwaZulu-Natal, Durban, South Africa
PhDAnthonet Lombard Koen
2South African Medical Research Council, Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
MBChBJohan J. Lombaard
3Josha Research Centre, Bloemfontein, Free State, South Africa
MBChBRosie Mngqibisa
4Paediatric Infectious Diseases Unit, University of KwaZulu-Natal, Durban, South Africa
MBChBAs’ad Ebrahim Bhorat
5Soweto Clinical Trials Centre, Johannesburg, South Africa
MBBChGabriella Benadé
6Wits Reproductive Health and HIV Institute, University of the Witwatersrand, Johannesburg, South Africa
MBBS, MPHNatasha Lalloo
7Respiratory and Critical Care Unit, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa
MBChBAnnah Pitsi
8Setshaba Research Centre, Tshwane, South Africa
MBChBPieter-Louis Vollgraaff
11Limpopo Clinical Research Initiative, Rustenburg, North-West, South Africa
MBChBAngelique Luabeya
13South African TB Vaccine Initiative, University of Cape Town, Cape Town, South Africa
MBChBAliasgar Esmail
15Centre for Lung Infection and Immunity, Division of Pulmonology, Department of Medicine and UCT Lung Institute, University of Cape Town, Cape Town, South Africa
MBChBFriedrich G. Petrick
17MERC Research, Middelburg, South Africa
MBChBAylin Oommen Jose
2South African Medical Research Council, Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
MBChBSharne Foulkes
3Josha Research Centre, Bloemfontein, Free State, South Africa
MBChBKhatija Ahmed
8Setshaba Research Centre, Tshwane, South Africa
MBChBAsha Thombrayil
2South African Medical Research Council, Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
MBChBLou Fries
1Novavax, Inc., 20 Firstfield Road, Gaithersburg, MD, USA
MDShane Cloney-Clark
1Novavax, Inc., 20 Firstfield Road, Gaithersburg, MD, USA
BSMingzhu Zhu
1Novavax, Inc., 20 Firstfield Road, Gaithersburg, MD, USA
PhDChijioke Bennett
1Novavax, Inc., 20 Firstfield Road, Gaithersburg, MD, USA
MD, MPH, MBAGary Albert
1Novavax, Inc., 20 Firstfield Road, Gaithersburg, MD, USA
MSEmmanuel Faust
1Novavax, Inc., 20 Firstfield Road, Gaithersburg, MD, USA
PhDJoyce S. Plested
1Novavax, Inc., 20 Firstfield Road, Gaithersburg, MD, USA
PhDAndreana Robertson
1Novavax, Inc., 20 Firstfield Road, Gaithersburg, MD, USA
MSSusan Neal
1Novavax, Inc., 20 Firstfield Road, Gaithersburg, MD, USA
BSIksung Cho
1Novavax, Inc., 20 Firstfield Road, Gaithersburg, MD, USA
MSGreg M. Glenn
1Novavax, Inc., 20 Firstfield Road, Gaithersburg, MD, USA
MDFilip Dubovsky
1Novavax, Inc., 20 Firstfield Road, Gaithersburg, MD, USA
MD, MPHShabir A. Madhi
2South African Medical Research Council, Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
MBBCh, PhD
Data Availability
These are interim data, and individual participants remain masked to individual vaccine assignment. Therefore, it would be inappropriate to share individual level results at this time.
https://clinicaltrials.gov/ct2/show/NCT04533399?term=NVX-CoV2373+Covid-19+Vaccine&draw=2&rank=2
Posted March 03, 2021.
Preliminary Efficacy of the NVX-CoV2373 Covid-19 Vaccine Against the B.1.351 Variant
Vivek Shinde, Sutika Bhikha, Zaheer Hoosain, Moherndran Archary, Qasim Bhorat, Lee Fairlie, Umesh Lalloo, Mduduzi S. L. Masilela, Dhayendre Moodley, Sherika Hanley, Leon Fouche, Cheryl Louw, Michele Tameris, Nishanta Singh, Ameena Goga, Keertan Dheda, Coert Grobbelaar, Gertruida Kruger, Nazira Carrim-Ganey, Vicky Baillie, Tulio de Oliveira, Anthonet Lombard Koen, Johan J. Lombaard, Rosie Mngqibisa, As’ad Ebrahim Bhorat, Gabriella Benadé, Natasha Lalloo, Annah Pitsi, Pieter-Louis Vollgraaff, Angelique Luabeya, Aliasgar Esmail, Friedrich G. Petrick, Aylin Oommen Jose, Sharne Foulkes, Khatija Ahmed, Asha Thombrayil, Lou Fries, Shane Cloney-Clark, Mingzhu Zhu, Chijioke Bennett, Gary Albert, Emmanuel Faust, Joyce S. Plested, Andreana Robertson, Susan Neal, Iksung Cho, Greg M. Glenn, Filip Dubovsky, Shabir A. Madhi, for the 2019nCoV-501 Study Group
medRxiv 2021.02.25.21252477; doi: https://doi.org/10.1101/2021.02.25.21252477
Preliminary Efficacy of the NVX-CoV2373 Covid-19 Vaccine Against the B.1.351 Variant
Vivek Shinde, Sutika Bhikha, Zaheer Hoosain, Moherndran Archary, Qasim Bhorat, Lee Fairlie, Umesh Lalloo, Mduduzi S. L. Masilela, Dhayendre Moodley, Sherika Hanley, Leon Fouche, Cheryl Louw, Michele Tameris, Nishanta Singh, Ameena Goga, Keertan Dheda, Coert Grobbelaar, Gertruida Kruger, Nazira Carrim-Ganey, Vicky Baillie, Tulio de Oliveira, Anthonet Lombard Koen, Johan J. Lombaard, Rosie Mngqibisa, As’ad Ebrahim Bhorat, Gabriella Benadé, Natasha Lalloo, Annah Pitsi, Pieter-Louis Vollgraaff, Angelique Luabeya, Aliasgar Esmail, Friedrich G. Petrick, Aylin Oommen Jose, Sharne Foulkes, Khatija Ahmed, Asha Thombrayil, Lou Fries, Shane Cloney-Clark, Mingzhu Zhu, Chijioke Bennett, Gary Albert, Emmanuel Faust, Joyce S. Plested, Andreana Robertson, Susan Neal, Iksung Cho, Greg M. Glenn, Filip Dubovsky, Shabir A. Madhi, for the 2019nCoV-501 Study Group
medRxiv 2021.02.25.21252477; doi: https://doi.org/10.1101/2021.02.25.21252477
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (668)
- Allergy and Immunology (668)
- Anesthesia (181)
- Cardiovascular Medicine (2648)
- Dermatology (223)
- Emergency Medicine (399)
- Epidemiology (12228)
- Forensic Medicine (10)
- Gastroenterology (759)
- Genetic and Genomic Medicine (4103)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2657)
- Health Policy (1005)
- Hematology (363)
- HIV/AIDS (851)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (436)
- Neurology (3882)
- Nursing (209)
- Nutrition (577)
- Oncology (2030)
- Ophthalmology (585)
- Orthopedics (240)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1115)
- Primary Care Research (452)
- Public and Global Health (6527)
- Radiology and Imaging (1403)
- Respiratory Medicine (871)
- Rheumatology (409)
- Sports Medicine (342)
- Surgery (448)
- Toxicology (53)
- Transplantation (185)
- Urology (165)